2013
DOI: 10.3109/08820538.2013.825281
|View full text |Cite
|
Sign up to set email alerts
|

Von Hippel-Lindau Disease: A Genetic and Clinical Review

Abstract: Understanding of the mechanisms and genetics underlying VHL and its associated retinal hemangioblastomas has increased substantially in recent years. This knowledge suggests that future advances may include better identification of individuals at higher risk of vision loss and the development of novel individualized therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
32
0
5

Year Published

2014
2014
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 48 publications
(37 citation statements)
references
References 72 publications
0
32
0
5
Order By: Relevance
“…However, most data pertain to angiogenic tumors (43,45,46). So far, no epidemiological data describe the relationship between VHL diseases and viral infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, most data pertain to angiogenic tumors (43,45,46). So far, no epidemiological data describe the relationship between VHL diseases and viral infection.…”
Section: Discussionmentioning
confidence: 99%
“…As a well-known disorder, VHL disease has attracted much attention from clinicians and biologists (43)(44)(45)(46), culminating in the collection of much clinical and epidemiological data. However, most data pertain to angiogenic tumors (43,45,46).…”
Section: Discussionmentioning
confidence: 99%
“…Patients with a complete deletion of the VHL gene have been found to have increased visual acuity and decreased incidence of retinal hemangioblastoma when compared with patients with a missense mutation. [10]…”
Section: Discussionmentioning
confidence: 99%
“…Patients with von Hippel-Lindau syndrome are predisposed to develop SCAs, as well as a variety of other clear cell neoplasms. The syndrome is caused by a germline (autosomal dominant) mutation of VHL with inactivating alteration or loss of the other functioning allele, further highlighting the critical role of this gene in SCA formation [108]. VHL alterations (intragenic mutations or LOH at 3p) can be used to help identify a cystic tumor as an SCA, and since virtually all SCAs are benign, these patients, if asymptomatic, can be safely followed up and unnecessary surgery can be avoided.…”
Section: Serous Cystadenomasmentioning
confidence: 99%